Dublin, July 05, 2018 (GLOBE NEWSWIRE) -- The "Cholesterol Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive analytics for Cholesterol Screening and Lab Testing Services for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Cholesterol Testing in US$ Thousand. The report profiles 29 companies including many key and niche players such as:
- Abbott Laboratories (USA)
- AccuTech, LLC (USA)
- Akers Biosciences, Inc. (USA)
- Alere Inc. (USA)
- Beckman Coulter, Inc. (USA)
- Bio-Rad Laboratories, Inc. (USA)
- Eurofins Scientific (Luxembourg)
- Boston Heart Diagnostics Corporation (USA)
- Home Access Health Corporation (USA)
- Laboratory Corporation of America Holdings (USA)
- PRIMA Lab SA (Switzerland)
- PTS Diagnostics (USA)
- Quest Diagnostics, Inc. (USA)
- Randox Laboratories Ltd. (UK)
- Roche Diagnostics (USA)
- Sekisui Diagnostics, LLC (USA)
- Siemens Healthineers (Germany)
- Sigma-Aldrich Corp. (USA)
Key Topics Covered
1. INDUSTRY OVERVIEW Cholesterol Testing An Overview Prevailing Scenario in the Global Healthcare Sector Favors Market Growth Increasing Healthcare Expenditure Wider Availability of Healthcare & Diagnostics Services Growing Health-Consciousness Lenience Towards Preventive Care Developed Regions Remain Key Revenue Contributors Developing Economies Offer Significant Potential Key Factors Driving Demand for Healthcare Services in Developing Regions Competitive Scenario Cholesterol Screening Services Market Structure Cholesterol Test Equipment Market Leading Players M&A Activity 2. NOTEWORTHY MARKET TRENDS, DRIVERS & CHALLENGES Growing Prevalence of Cardiovascular Disease Steers Demand for Cholesterol Testing Global Menace of Cardiovascular Disease: Quick Facts A Brief Overview of Select Cholesterol-Driven Cardiac Disorders CVD Statistics Risk of CVD in Obese People Underpins Cholesterol Testing Volumes Global Obesity Facts in a Nutshell Cholesterol Screening Assumes Importance in Diabetes Care The Hypertension-Cholesterol Link Accelerates the Need for Cholesterol Screening Aging Population A Vital Demography Uptrend in In-Vitro Diagnostics (IVD) Sector Signals Prospects Healthy Growth in Cardiac IVD Market Augments Market Potential Positive Momentum in Point of Care (POC) Diagnostics Generates Parallel Opportunities POC Diagnostics An Overview POC Cholesterol Testing Makes Rapid Gains Massive Demand for Lipid Panel/Lipid Profile Tests Northbound Trajectory in POC LPT Services Rise of C-reactive Protein Tests to Aid Market Growth Cholesterol Testing: Evolution from Invasive to Non-Invasive Recent Breakthroughs in Non-Invasive Cholesterol Testing Domain Nonfasting Lipid Testing Invalidates the Need for Pre-Test Fasting Cloud Screening Platforms Extend New Level of Convenience Self-Testing Kits: An Emerging Issue for Full-Scale Services Providers A Rapidly Evolving Market Enabled by Technology Opportunities & Challenges in Self-Testing Industry E-Retailing Drives Sales of Home Test Kits A Brief Overview of Select Cholesterol Test Kits 3. CHOLESTEROL TESTING: A BROADER PERSPECTIVE Blood Cholesterol The Principal Cardiac Risk Marker Types of Cholesterol Total Cholesterol (TC) High Density Lipoprotein (HDL) Low Density Lipoprotein (LDL) / Very Low Density Lipoprotein (VLDL) Triglycerides (TRG) Glucose (GLU) Alanine Aminotransferase (ALT) Outcomes of High Blood Cholesterol Atherosclerosis Coronary Heart Disease (CHD) Risk Factors and Risk Levels Risk Factors Risk Levels Risk Level Classification under National Heart, Risk Level Based on Total Cholesterol Concentration Cholesterol Testing & CVD Risk Assessment Techniques Need for Cholesterol Testing Candidates for Cholesterol Testing Test Procedure Time of Testing Crucial for Heart Disease Patients Types of Cholesterol Testing Cholesterol Screening & Lab Testing Services Providers Cholesterol Control & Treatment Modalities Dietary Therapy Drug Therapy 4. PRODUCT/SERVICE INTRODUCTIONS Quest Diagnostics Rolls Out Non-Fasting Cholesterol Tests VAP Diagnostics Lab Relaunches VAP+ Lipid Panel Bio-Rad Laboratories Unveils Bio-Plex Pro Human Apolipoprotein Panel Color Genomics Launches New Test for Hereditary High Cholesterol Admera Health Unveils New DNA Tests Mayo Clinic Launches Blood Test to Predict Adverse Cardiovascular Events Using Plasma Ceramides PTS Diagnostics Rolls Out PTS Connect Wellness Solution 5. RECENT INDUSTRY ACTIVITY Abbott Laboratories to Acquire Alere Siemens Healthineers to Expand Massachusetts Facility PTS Bags USFDA Clearance for New Measurement Range for PTS Panels Alere to Divest Triage Assets to Quidel Akers Biosciences Inks Distribution Agreement with First Check Diagnostics Merck to Split into Three Separate Businesses Atonomics Receives CE Marking for Trace Lipids Test Panel Siemens Healthineers Partners with DiA Holding PTS Diagnostics Inks Distribution Agreement with Anda PTS Diagnostics Renews Multi-Year Agreement with Life Line Screening Siemens Healthcare Rebrands itself as Siemens Healthineers Sinocare Acquires PTS Diagnostics Eurofins Snaps Up Boston Heart Diagnostics Merck Acquires Sigma-Aldrich Optum Snaps Up Alere Health from Alere PTS Diagnostics Collaborates with Blinded Diagnostics 6. FOCUS ON SELECT GLOBAL PLAYERS Abbott Laboratories (USA) AccuTech, LLC (USA) Akers Biosciences, Inc. (USA) Alere Inc. (USA) Beckman Coulter, Inc. (USA) Bio-Rad Laboratories, Inc. (USA) Eurofins Scientific (Luxembourg) Boston Heart Diagnostics Corporation (USA) Home Access Health Corporation (USA) Laboratory Corporation of America Holdings (USA) PRIMA Lab SA (Switzerland) PTS Diagnostics (USA) Quest Diagnostics, Inc. (USA) Randox Laboratories Ltd. (UK) Roche Diagnostics (USA) Sekisui Diagnostics, LLC (USA) Siemens Healthineers (Germany) Sigma-Aldrich Corp. (USA) 7. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 29
- The United States (23)
- Canada (1)
- Japan (1)
- Europe (2)
- Germany (1)
- The United Kingdom (1)
- Asia-Pacific (Excluding Japan) (2)
For more information about this report visit https://www.researchandmarkets.com/research/t...terol?w=12
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Cholesterol Testing
